Journal article
Atrial Fibrillation: Modern Concepts and Management
Annual review of medicine, v 56(1), pp 475-494
01 Feb 2005
PMID: 15660523
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Atrial fibrillation (AF) is a common cardiac arrhythmia responsible for significant morbidity and mortality. In recent years, progress has been made in determining the genetic abnormalities that may lead to AF. New trials have shown that rate control and anticoagulation are acceptable as a primary treatment strategy in many patients who have a high risk of recurrence. Newer and safer antiarrhythmics are now available. Pacemaker and implantable cardiac defibrillator technology is rapidly evolving and may play a significant role in future treatment and prevention of AF. Direct thrombin inhibitors are likely to add a user-friendly option to the current standard therapy for stroke prevention.
Metrics
Details
- Title
- Atrial Fibrillation: Modern Concepts and Management
- Creators
- Ashish Agarwal - Drexel UniversityMeghan York - Drexel UniversityBharat K. Kantharia - Einstein Medical Center PhiladelphiaMichael Ezekowitz - Drexel UniversityAkash Agarwal - Surgery
- Publication Details
- Annual review of medicine, v 56(1), pp 475-494
- Publisher
- Annual Reviews
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Surgery
- Web of Science ID
- WOS:000227504100026
- Scopus ID
- 2-s2.0-14544292084
- Other Identifier
- 991019168150504721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Web of Science research areas
- Medicine, Research & Experimental